Zurueck zur Suche

Reporte zur Charge U019291

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

18Reporte angezeigt
0Todesfaelle
1Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
NY 4 TX 2 AR 2 VA 1 CA 1 MS 1 UT 1 TN 1 CO 1 IN 1 NM 1 NC 1

VAERS 2367380

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019291

mild
Staat
TX
Alter
1,2
Geschlecht
M
Eingang
13.07.2022
Impfdatum
29.06.2022
Beginn
08.07.2022
Tage bis Beginn
9,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Infection Rash morbilliform

Symptomtext

Measles like rash within 14 days of infection, no fever, well appearing

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash morbilliform
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2329010

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019291

mild
Staat
AR
Alter
1,1
Geschlecht
F
Eingang
23.06.2022
Impfdatum
03.06.2022
Beginn
14.06.2022
Tage bis Beginn
11,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash Rash macular Rash papular

Symptomtext

Rash began on her torso and face. Very small pink dots. Was not raised. The next morning the rash was much worse, Covering all of her face, into her scalp. Rash spread to her arms and legs on day #2 and 3. Slightly raised. She was not bothered by rash, did not have a fever. She still currently has small pink dots that are not as bright pink as on day #2 and Day #3.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
None
Allergien
none
Vorherige Impfungen
-

VAERS 2317254

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019291

mild
Staat
VA
Alter
70,0
Geschlecht
F
Eingang
13.06.2022
Impfdatum
26.05.2022
Beginn
27.05.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Balance disorder Dizziness Headache Pain

Symptomtext

Body aches, headache, light headedness, imbalance and left sided joint pain. Appointment with Dr.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
Hypertension and Hypothyroidism
Andere Medikamente
Potassium, Octi Health Supplement, B12 and Folic Acid, Promethazine, levothyroxine, HCTZ and Vitamins D and E
Allergien
Cilantro, Codeine and Sulfa
Vorherige Impfungen
-

VAERS 2314568

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u019291

mild
Staat
CA
Alter
4,0
Geschlecht
F
Eingang
09.06.2022
Impfdatum
06.06.2022
Beginn
07.06.2022
Tage bis Beginn
1,0
Dosis
5
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site pain Injection site swelling

Symptomtext

Left Upper Arm pain and swelling around site of injection.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site pain
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2290926

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u019291

mild
Staat
AR
Alter
1,0
Geschlecht
M
Eingang
23.05.2022
Impfdatum
10.05.2022
Beginn
18.05.2022
Tage bis Beginn
8,0
Dosis
1
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja
Band neutrophil percentage Blood culture negative Blood fibrinogen normal C-reactive protein increased Culture urine negative Enterovirus test positive Eosinophil percentage decreased Erythema multiforme Full blood count Human rhinovirus test positive Lymphocyte percentage increased Neutrophil percentage decreased Procalcitonin Pyrexia Rash Rash erythematous Rash macular Red blood cell sedimentation rate normal

Symptomtext

Patient vaccinated 5/10. At same time diagnosed with acute otitis media and prescribed amoxicillin twice daily. No missed doses. Starting 5/18 PM was noted to have erythematous patchy rash on trunk and lower extremities. 5/19 started with fever (102F rectal), rash spread to include larger erythematous patches with dusky centers. Patient was advised to stop amoxicillin after taking AM dose on 5/19, transitioned to azithromycin. 5/20 progression of rash to targetoid lesions. presented to ED on 5/21 with diffuse erythematous rash on trunk with some scattered macular areas on neck and extremities. Pt evaluated by pediatric infectious diseases and diagnosed with erythema multiforme, suspect related to amoxicillin. Patient treated with supportive care with full resolution of symptoms and discharge on 5/23/22.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
2,0
Labordaten
5/21: CBC 9.9>10<309, 24% neutrophils, 30% bands, 46% lymphocytes, no eosinophils; ESR 10mm/hr; CRP 87mg/L; procalcitonin 0.9; fibrinogen wnl; HS trophonin wnl: COVID 19: IgG: reactive (quant: 3.43); RVP: rhino/enterovirus positive; UA: normal; blood and urine cultures remain negative.
Aktuelle Erkrankungen
Acute otitis media diagnosed at well child visit were he received his 12mo vaccines.
Vorgeschichte
none
Andere Medikamente
Prescribed 5/10/22 (same day as vaccination) amoxicillin, dose unknown, for acute otitis media. Completed 8 days. Discontinued on 5/18/22 due to new onset rash (later diagnosed as erythema multiforme) with concern for adverse drug reaction
Allergien
none prior to event
Vorherige Impfungen
-

VAERS 2260361

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019291

mild
Staat
MS
Alter
1,0
Geschlecht
M
Eingang
02.05.2022
Impfdatum
25.04.2022
Beginn
27.04.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
SC / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Decreased appetite Irritability Pyrexia Rash Rash erythematous Rash pruritic Rash vesicular Teething Urticaria Viral rash

Symptomtext

Patient given 12 months vaccines on 4/25/22 (MMR II, Varivax, Prevnar 13). 2 days later on 4/27/22 mother reports that child started with rash to abdomen, chest, and back, that also present to arms and legs at times. The rash was red flat areas with some whelps. Itchy rash to child. The rash would come and go and still present. Presented today for an appointment. Looks similar to vaccine Varicella like rash versus viral rash. X2 insect bites with some redness to right posterior leg. Fevers, irritability, and poor appetite for 3-4 days after vaccines. Still some clinging and decreased appetite. Child also teething. Denies SOB or difficulty breathing, denies swelling lips/tongue. Rash is worse with hot bath or playing

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
No Known Allergies
Vorherige Impfungen
-

VAERS 2258169

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u019291

mild
Staat
UT
Alter
27,0
Geschlecht
F
Eingang
29.04.2022
Impfdatum
11.04.2022
Beginn
21.04.2022
Tage bis Beginn
10,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Rash

Symptomtext

Site: Redness at Injection Site-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Additional Details: she developed rash on the left side of her body about 2 weeks after the vaccine. mmr vaccine was given sc in left arm. started with small rash and got larger. got rx from dr today 4/25/22 for triamcinolone crm and an antifungal crm. is going on beach vacation soon and wants rash resolved.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2647199

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019291

gering
Staat
TN
Alter
4,0
Geschlecht
F
Eingang
20.06.2023
Impfdatum
19.06.2023
Beginn
19.06.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

Patient was given an MMR vaccine that was expired by 1 day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
None, patient has not had an adverse reaction.
Aktuelle Erkrankungen
asthma
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2455525

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019291

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
23.09.2022
Impfdatum
-
Beginn
31.08.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

Confirmed with caller no other AE occurred; Customer reported an AE for VARIVAX and MMRII. The caller said these products were administered to the patient after two temperature excursions occurred; This spontaneous report has been received from a consumer concerning a patient of unknown age and gender. The patient's medical history, drug reactions or allergies, concurrent conditions and concomitant medications were not reported. On an unknown date, two temperature excursions occurred for varicella virus vaccine live (oka/merck) (VARIVAX) and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) with a temperature of 5.9 and 8.8 degrees Celsius, for a time frame of 10 and 8 hours. No previous temperature excursions were reported. On 31-AUG-2022, the patient was administered varicella virus vaccine live (oka/merck) (VARIVAX) 1 dose, lot # U028164, expiration date 09-SEP-2023; and measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin [rHA]) (M-M-R II) 1 dose, lot # U019291 expiration date 18-JUN-2023 (route of administration and anatomical location were not provided) both as prophylaxis (product storage error). No other events were reported (no adverse event).; Sender's Comments: US-009507513-2209USA003954: US-009507513-2209USA004005:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2452932

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019291

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
21.09.2022
Impfdatum
02.09.2022
Beginn
02.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

No other adverse events occurred; The caller said these products were administered to the patient after two temperature excursions occurred.; This spontaneous report was received from a consumer concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 02-SEP-2022, the patient was vaccinated with 1 dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) subcutaneous injection, lot #U019291, expiration date: 18-JUN-2023 (strength, and route of administration were not provided); and 1 dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U028164, expiration date: 09-SEP-2023 (strength, and route of administration were not provided), both administered as prophylaxis. The reporter stated that the vaccines experienced two temperature excursions at a temperature of 5.9 Celsius degrees (C) for 10 hours and 8.8C for 8 hours (Product storage error). There were no previous temperature excursions and no other adverse events reported. This is one of three reports received from the same source.; Sender's Comments: US-009507513-2209USA003954: US-009507513-2209USA004041:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2451754

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019291

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
20.09.2022
Impfdatum
02.09.2022
Beginn
02.09.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no other adverse event occurred; Customer reported an AE for VARIVAX and MMRII. The caller said these products were administered to the patient after two temperature excursions occurred. Confirmed with caller no other AE occurred. Caller did not specify if she could be contacted. AE; This spontaneous report was received from a consumer concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 02-SEP-2022, the patient was vaccinated with 1 dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) subcutaneous injection, lot #U019291, expiration date: 18-JUN-2023, (strength, and route of administration were not provided); and 1 dose of varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot #U028164, expiration date: 09-SEP-2023, (strength, and route of administration were not provided), both administered as prophylaxis. The reporter stated that the vaccines were administered to the patient after two temperature excursions at a temperature of 5.9 Celsius degrees (C) for 10 hours, and 8.8C for 8 hours (product storage error). There were no previous temperature excursions and no other adverse events reported. This is one of several reports received from the same source.; Sender's Comments: US-009507513-2209USA004041:

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2428200

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019291

gering
Staat
CO
Alter
25,0
Geschlecht
M
Eingang
02.09.2022
Impfdatum
02.09.2022
Beginn
02.09.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Electrocardiogram normal Hyperhidrosis Hypophagia Laboratory test Lethargy Pallor Pulse abnormal

Symptomtext

Patient was given Varivax subcutaneous in left arm tricep area, MMR II right arm tricep area, and Hepatitis B Hepislav-B IM in left deltoid around 11:45 AM in a clinic setting by me. After giving all vaccines patient became lethargic, diaphoretic, pallor, and had a thready pulse of 20-30s after 1 minute. Patient legs were elevated and patient was reclined on exam table. EMS was called and patient remained lethargic, pale, with pulse in 20-30s, with pulse oximeter of 85% on room air (we do not have oxygen in this clinic). Gave patient an ammonia inhalant and patient began to be more conversant after 5 minutes. Pulse now in 40-50s. Paramedics arrived after 5 minutes, patient now alert and oriented, EKG performed and patient was in sinus rhythm. Patient was taken to Hospital for further work up but was discharged around 2:00 PM. Patient came back by clinic to thank clinic staff. Patient did inform staff after the situation that he had not eaten, had worked out and taken pre-workout before vaccination appointment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electrocardiogram normal
Hospital-Tage
-
Labordaten
9/2 EKG-sinus rhythm
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2410151

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019291

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
12.08.2022
Impfdatum
19.07.2022
Beginn
19.07.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

No additional AE details were provided. No PQC.; Nurse calling in to report an AE for a patient that was administered a dose of MMR-II reconstituted with expired STERILE DILUENT. Per caller the patient was administered the dose of MMR-II today 19JUL2022 and the STERILE DILUENT expired 1JUL2022.; Nurse calling in to report an AE for a patient that was administered a dose of MMR-II reconstituted with expired STERILE DILUENT. Per caller the patient was administered the dose of MMR-II today 19JUL2022 and the STERILE DILUENT expired 1JUL2022.; This spontaneous report was received from a registered nurse concerning a patient of unknown gender and age. The patient's concomitant therapies, pertinent medical history, and drug reactions/allergies were not reported. On 19-JUL-2022, the patient was administered with a dose of 0.5 mL measles, mumps, and rubella (wistar RA 27-3) virus vaccine, live (recombinant human albumin (rHA)) (M-M-R II) (lot # U019291, expiration date 18-JUN-2023; strength was not reported), reconstituted with expired sterile diluent (STERILE DILUENT) (lot # S037027, expiration date 01-JUL-2022; strength was not reported) subcutaneously for prophylaxis (expired product administered, product preparation issue). No additional adverse event (AE) details were provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
STERILE DILUENT
Allergien
-
Vorherige Impfungen
-

VAERS 2399237

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019291

gering
Staat
IN
Alter
11,0
Geschlecht
M
Eingang
02.08.2022
Impfdatum
01.08.2022
Beginn
01.08.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered

Symptomtext

A 3rd dose of MMR was given by mistake. The patient had requested a menactra for school however the appointment was made for an MMR. Per vaccination site the patient did not have a 2nd dose of MMR so the dose was given. However, when the patient came back with a vaccination card a 2nd dose was given 4/3/2015 at another location. So the patient got 3 total doses of MMR. The patient is ok no side effects or concerns.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2388123

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019291

gering
Staat
NM
Alter
44,0
Geschlecht
F
Eingang
25.07.2022
Impfdatum
25.05.2022
Beginn
25.05.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SC / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Wrong product administered

Symptomtext

Patient scheduled for MMR but received Varicella vaccine instead. Error caught and MMR documented as administered on 5/25/22 as well. No adverse effects documented from administration of Varicella vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
na
Aktuelle Erkrankungen
na
Vorgeschichte
HTN, OSA, GERD, hypothyroid, anxiety, prediabetes
Andere Medikamente
Buspar, chlorthalidone, citalopram, clonidine, ibuprofen, norgestimate-ethinyl estradiol, Omega 3, omeprazole, potassium chloride, NP Thyroid
Allergien
penicillin, Wellbutrin
Vorherige Impfungen
-

VAERS 2329065

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019291

gering
Staat
NC
Alter
4,0
Geschlecht
F
Eingang
23.06.2022
Impfdatum
21.06.2022
Beginn
22.06.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Salivary hypersecretion Strawberry tongue

Symptomtext

Strawberry tongue and excessive saliva

Weitere VAERSDATA-Felder
Praegender Schweregrund
Salivary hypersecretion
Hospital-Tage
-
Labordaten
Physical exam
Aktuelle Erkrankungen
None
Vorgeschichte
none
Andere Medikamente
Clartian and montelukast
Allergien
None
Vorherige Impfungen
-

VAERS 2327102

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge U019291

gering
Staat
TX
Alter
31,0
Geschlecht
M
Eingang
22.06.2022
Impfdatum
22.06.2022
Beginn
22.06.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SC / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect route of product administration

Symptomtext

ADMINISTRATION ERROR: A Moderna Booster 0.25 mL was given by the Intradermal route instead of by the Intramuscular route when both a TB skin test and the Moderna booster were to be administered at the same visit. Vaccines were administered by RN.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2187738

MERCK & CO. INC. · MEASLES + MUMPS + RUBELLA (MMR II) · Charge u019291

gering
Staat
FL
Alter
39,0
Geschlecht
M
Eingang
18.03.2022
Impfdatum
18.03.2022
Beginn
18.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration

Symptomtext

no adverse reaction. Gave patient dose IM instead of SQ. Manufacturer said it was okay and not to repeat dose. Patient is aware

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-